ARTICLE | Company News
Astellas, U.S. Department of Justice infectious news
April 21, 2014 7:00 AM UTC
Astellas will pay $7.3 million to the U.S. Department of Justice to resolve civil claims alleging off-label promotion of antifungal drug Mycamine micafungin. The DoJ investigated the pharma for off-l...